| 201 |
New series of 4, 6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 202 |
Peripherally restricted PICK1 inhibitor mPD5 ameliorates pain behaviors in murine inflammatory and neuropathic pain models |
Department of Pharmacology |
2024 |
| 203 |
Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit incidence, types, and acceptability |
Department of Clinical Pharmacy |
2024 |
| 204 |
Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability |
Department of Clinical Pharmacy |
2024 |
| 205 |
Phenotypic detection of ESBL and MBL producing Klebsiella pneumoniae in critically ill patients with nosocomial pneumonia |
Department of Microbiology and Immunology |
2024 |
| 206 |
Phytochemical Screening and chemical investigation of lipoidal matter of the leaves of Latania verschaffeltii Lem. Family Arecaceae cultivated in Egypt |
Department of Pharmacognosy |
2024 |
| 207 |
Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies |
Department of Medicinal Chemistry |
2024 |
| 208 |
Prednisolone loaded-cationic nanoemulsion formulation for uveitis management |
Department of Pharmaceutics |
2024 |
| 209 |
Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma |
Department of Medicinal Chemistry |
2024 |
| 210 |
Recent trends in the delivery of RNA drugs: Beyond the liver, more than vaccine |
Department of Industrial Pharmacy |
2024 |